Combined First Month Body Weight Loss and Development of Tolerance as Predictors of 6-Month Efficacy of Mazindol in Mild and Moderate Obese Subjects.

J Clin Med · 2022 · PMC9181115 · PMID 35683598

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

Additionally, there was a clear trend between 1mo-BWRkg and moT with a progressive weight reduction induced by mazindol by month 6, which was confirmed by the existence of significant correlations in both cases.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.